The GRAIT Awards Program is particularly interested in innovative ideas in the field of immune thrombocytopenia (ITP) or in the mechanism of action of Spleen Tyrosine Kinase (SYK) inhibition.

Proposals aimed to provide novel insights into the diagnosis, clinical course, quality of life, management of ITP or to increase knowledge of the SYK inhibition as mechanism of action, are invited to enter.

The GRAIT Awards program offers 1 award of Eur 50,000 to the participant (either an individual or a team) whose proposal best matches the program's objectives as assessed by an independent Review Committee.

The GRAIT Awards Program aims to:

  • Improve awareness, diagnosis clinical course and management of ITP

  • Increase knowledge of Spleen Tyrosine Kinase (SYK) inhibition as mechanism of action